Please use this identifier to cite or link to this item: http://repository.ush.edu.sd:8080/xmlui/handle/123456789/684
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMohammed, Osman Ali-
dc.contributor.authorIbrahim, Bakhit Yousif-
dc.contributor.authorIhsan, Mohammed Osman-
dc.contributor.authorElfatih, Mohammed Abdallah-
dc.contributor.authorAbdelwahab, Abdien Saeed-
dc.date.accessioned2019-07-10T08:58:36Z-
dc.date.available2019-07-10T08:58:36Z-
dc.date.issued2019-06-
dc.identifier.issn2349-0063-
dc.identifier.urihttp://hdl.handle.net/123456789/684-
dc.descriptionBreast cancer is the most frequently diagnosed and the leading cause of cancer death in women globally. Over the past few decades its incidence has increased but a fall in mortality has been observed due to improvement in survival which is associated with earlier disease detection. This is a prospective cross-sectional descriptive study based on laboratory data of (136) patients with breast cancer carried out from (2012-2017) in Nuclear Medicine and Cancer Research centre - Shendi University and Nuclear Medicine and Cancer Research Centre - Aljazeera University. The investigations were performed on venous blood sample drawn in EDTA container for complete blood count by using auto haematology analyzer (Mindray BC-3000 plus). Regarding anemia among breast cancer, 61/136 (44.9 %) were anemic, while 75/136 (55.1 %) were non anemic. There is high frequency of cancer related anaemia in breast cancer (44.9 %).en_US
dc.description.abstractBreast cancer is the most frequently diagnosed and the leading cause of cancer death in women globally. Over the past few decades its incidence has increased but a fall in mortality has been observed due to improvement in survival which is associated with earlier disease detection. This is a prospective cross-sectional descriptive study based on laboratory data of (136) patients with breast cancer carried out from (2012-2017) in Nuclear Medicine and Cancer Research centre - Shendi University and Nuclear Medicine and Cancer Research Centre - Aljazeera University. The investigations were performed on venous blood sample drawn in EDTA container for complete blood count by using auto haematology analyzer (Mindray BC-3000 plus). Regarding anemia among breast cancer, 61/136 (44.9 %) were anemic, while 75/136 (55.1 %) were non anemic. There is high frequency of cancer related anaemia in breast cancer (44.9 %).en_US
dc.language.isoen_USen_US
dc.publisherWorld Journal of Biology and Medical Sciencesen_US
dc.relation.ispartofseriesVolume 6,;Issue-2, 17-22, April - June, 2019-
dc.subjectBreast canceren_US
dc.subjectSudanen_US
dc.subjectAnaemiaen_US
dc.subjectcanceren_US
dc.subjectBreasten_US
dc.titleBreast Cancer Related Anaemiasen_US
dc.typeArticleen_US
Appears in Collections:Researches and Scientific Papers البحوث والأوراق العلمية

Files in This Item:
File Description SizeFormat 
3. Breast Cancer Related 17-22.pdf1.02 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.